One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age
Biologics in Therapy · 2014
DOI: 10.1007/s13554-014-0014-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biologics in Therapy, 2014. Verfasst von Hans-Peter Schwarz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, von Haunersches Kinderspital, University Hospital Munich, Munich, Germany. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: This prospective, open-label, non-comparative, multicentre, long-term phase IV study is examining the efficacy and safety of somatropin [recombinant human growth hormone (rhGH)] in short children born small for gestational age (SGA) and its impact on the incidence of diabetes. This report is the first interim analysis of patients who have completed 1 year of treatment. METHODS: A total of 278 pre-pubertal patients were enrolled. Key eligibility criteria included height standard deviation score (HSDS)
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, von Haunersches Kinderspital, University Hospital Munich, Munich, Germany.
- Medical University, Gdansk, Poland.
- Department of Endocrinology, Children's Health Research Institute, Warsaw, Poland.
- Department of Paediatric Endocrinology and Diabetology, Pomeranian Medical University, Szczecin, Poland.
- Department of Endocrinology, University of Medicine and Pharmacy "Gr.T.Popa", Iasi, Romania.
- Department of Endocrinology, Tblisi State Medical University, Tblisi, Georgia.
Zitieren
APA
Schwarz, H. P., Birkholz-Walerzak, D., Szalecki, M., Walczak, M., Galesanu, C., Metreveli, D., Khan-Boluki, J., & Schuck, E. (2014). One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age. Biologics in Therapy. https://doi.org/10.1007/s13554-014-0014-4
Vancouver
Schwarz HP, Birkholz-Walerzak D, Szalecki M, Walczak M, Galesanu C, Metreveli D, et al. One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age. Biologics in Therapy. 2014. doi:10.1007/s13554-014-0014-4
BibTeX
@article{Schwarz2014,
author = {Schwarz, Hans-Peter and Birkholz-Walerzak, Dorota and Szalecki, Mieczyslaw and Walczak, Mieczyslaw and Galesanu, Corina and Metreveli, David and Khan-Boluki, Jasmin and Schuck, Ellen},
title = {One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age},
journal = {Biologics in Therapy},
year = {2014},
doi = {10.1007/s13554-014-0014-4}
}
EUVIMED